Appendix 4E Preliminary Final Report
Filed with ASX · · 3 pages · English
Summary by 6ix AI
The report indicates a significant decrease in revenues from ordinary activities compared to the previous year, alongside an increase in losses attributable to the owners of the company. The company raised substantial funds through a capital raise to support its strategic expansion, resulting in a notable increase in net assets. No dividends were declared during the current financial period, consistent with the previous period's results.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Optiscan Imaging Limited on 6ix
Earlier from Optiscan Imaging
- Optiscan Signs MOU with University of Minnesota
- OIL June 2024 Quarterly Report and Appendix 4C
- Optiscan Delivers Major Milestone in Telepathology Platform
- Optiscan Receives Ethical Clearance for Breast Cancer Study
- Optiscan 2024 Roadshow Presentation
Later from Optiscan Imaging
- OIL September 2024 Quarterly Report and Appendix 4C
- Optiscan Signs Agreement with Monash to Progress GI Scope
- Optiscan Signs Research Agreement with Minnesota Vet College
- OIL Managing Director's Presentation & Chair's Address
- Optiscan receives $1.775m R&D Tax Refund
Follow Optiscan Imaging into a list and get an email when it puts out news.
Follow Optiscan Imaging